Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/1995
12/05/1995US5472692 Causes less fibrinogenolysis than native pro-urokinase; thrombolytic agents
12/02/1995CA2150612A1 Process for producing albumin preparation
12/02/1995CA2125120A1 Nucleotide sequences and methods for detection of serpulina hyodysenteriae
11/1995
11/30/1995WO1995032430A2 Assay for pathogenicity of anti-dna antibodies
11/30/1995WO1995032310A1 Identification and use of antiviral compounds
11/30/1995WO1995032309A1 Treatment of influenza virus infection using antivirals that inhibit acylation/palmitylation of hemagglutinin
11/30/1995WO1995032308A1 Compositions and uses thereof in the diagnosis of psoriasis
11/30/1995WO1995032307A1 Epstein-barr virus transcription factor binding assay
11/30/1995WO1995032305A1 Pna probes for detection of neisseria gonorrhoeae and chlamydia trachomatis
11/30/1995WO1995032302A1 Dna encoding glutamate gated chloride channels
11/30/1995WO1995032300A1 Selective biological destruction of tumor cells
11/30/1995WO1995032293A1 Assay for hiv-1 group o using at least one gp41 peptide
11/30/1995WO1995032292A2 Detection of viral antigens coded by reverse-reading frames
11/30/1995WO1995032291A2 Hepatitis g virus and molecular cloning thereof
11/30/1995WO1995032290A2 Non-a/non-b/non-c/non-d/non-e hepatitis agents and molecular cloning thereof
11/30/1995WO1995032289A1 Transformant line of candida utilis yeast and expression of heterogene therewith
11/30/1995WO1995032288A1 Nematode-induced genes in tomato
11/30/1995WO1995032287A1 Inducible defensin peptide from mammalian epithelia
11/30/1995WO1995032286A2 Immunogenic carcinoembryonic antigen and methods of use and production
11/30/1995WO1995032285A2 Transgenic arthritic mice
11/30/1995WO1995032284A1 Factor interacting with nuclear proteins
11/30/1995WO1995032282A1 Interleukin-6 splice variant
11/30/1995WO1995032225A1 Method for site-specific integration of nucleic acids and related products
11/30/1995WO1995032223A1 cDNA CLONING OF POTENTIALLY TRANSFORMING HUMAN ras-RELATED ONCOGENES
11/30/1995WO1995032222A1 Method for purifying somatotropin monomers
11/30/1995WO1995032221A2 Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy
11/30/1995WO1995032220A1 Cloned leptospira outer membrane protein
11/30/1995WO1995032219A1 Protein or polypeptide, process for producing the same, and intermediate compound tehrefor
11/30/1995WO1995032218A1 Neurotensin antagonist peptides
11/30/1995WO1995032216A1 Biologically active glycoprotein hormones produced in procaryotic cells
11/30/1995WO1995032214A1 A novel prostate/colon tumor suppressor gene located on human chromosome 8
11/30/1995WO1995032003A1 Modified insulin-like growth factors
11/30/1995WO1995032000A1 Hiv polyprotein immunogens
11/30/1995WO1995031999A1 Compositions of transactivating proteins of human immunodeficiency virus
11/30/1995WO1995031998A1 Candida albicans adhesin as a vaccine
11/30/1995WO1995031997A1 Model for testing immunogenicity of peptides
11/30/1995WO1995031995A1 Mimetics of senescent cell derived inhibitors of dna synthesis
11/30/1995WO1995031994A1 Peptides used as carriers in immunogenic constructs suitable for development of synthetic vaccines
11/30/1995WO1995031990A1 Copolymer-1 improvements in compositions of copolymers
11/30/1995WO1995031984A1 Method and reagents for the treatment of rheumatoid arthritis
11/30/1995WO1995031904A1 Methods for the identification of hiv anti-viral agents capable of abrogating integrase interactor protein binding
11/30/1995WO1995031901A1 METHODS FOR THE IDENTIFICATION OF COMPOUNDS CAPABLE OF ABROGATING HIV-1 Vpr-rip-1 BINDING INTERACTIONS
11/30/1995WO1995030002A3 Enhancing the sensitivity of tumor cells to therapies
11/30/1995WO1995029239A3 Compounds and methods for the stimulation and enhancement of protective immune responses and il-12 production
11/30/1995CA2191202A1 Peptides used as carriers in immunogenic constructs suitable for development of synthetic vaccines
11/30/1995CA2190999A1 Cloned leptospira outer membrane protein
11/30/1995CA2190972A1 Compositions of transactivating proteins of human immunodeficiency virus
11/30/1995CA2190860A1 Hepatitis g virus and molecular cloning thereof
11/30/1995CA2190752A1 Modified insulin-like growth factors
11/30/1995CA2190613A1 Methods for the identification of compounds capable of abrogating hiv-1 vpr-rip-1 binding interactions
11/30/1995CA2190587A1 Identification and use of antiviral compounds
11/30/1995CA2190581A1 Treatment of influenza virus infection using antivirals that inhibit acylation/palmitylation of hemagglutinin
11/30/1995CA2188582A1 Method and reagents for the treatment of rheumatoid arthritis
11/30/1995CA2188423A1 Factor interacting with nuclear proteins
11/30/1995CA2170627A1 A novel prostate/colon tumor suppressor gene located on human chromosome 8
11/29/1995EP0684313A2 Polypeptides with phytase activity
11/29/1995EP0684312A2 Preparation process of a natural protein sweetener
11/29/1995EP0684311A1 Vaccines against animal parasitic nematodes
11/29/1995EP0684310A1 Transgenic animals lacking proteolipid protein and method of making such animals
11/29/1995EP0684260A2 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof
11/29/1995EP0683821A1 Rna packaging system
11/29/1995EP0683818A1 Protein fusions for the translocation of apo-protein into the periplasmic space
11/29/1995EP0683817A1 Novel polypeptides having serotoninergic receptor activity, nucleic acids coding therefor and use thereof
11/29/1995EP0683791A1 Aqueous protein composition, glycoprotein contained therein, prepration method therefor and uses thereof
11/29/1995EP0683678A1 Method for inactivating viruses devoid of lipid envelopes
11/29/1995EP0460076B1 Genetically engineered immunoglobulins
11/29/1995EP0452314B1 Adhesion receptor for laminin and its use
11/29/1995EP0412116B1 Detection of neu gene expression and products
11/29/1995EP0359783B1 Treatment of autoimmune diseases by oral administration of autoantigens
11/29/1995EP0344320B1 Human monoclonal antibody against candida
11/29/1995CN1112795A A methodology for selecting superagonists, antagonists and superantagonists of hormones whose receptor complex includes GP 130
11/29/1995CN1112444A Treatment of infertility and enhancement of fertilization capacity in mammalian males
11/28/1995US5470997 Amphetamine derivatives and protein and polypeptide amphetamine derivative conjugates and labels
11/28/1995US5470974 Uncharged polynucleotide-binding polymers
11/28/1995US5470971 Stress-induced proteins, genes coding therefor, transformed cells of organisms, methods and applications
11/28/1995US5470970 Maspin, a serpin with tumor suppresing activity
11/28/1995US5470966 Neural α-catenin
11/28/1995US5470958 Antisera against a PEB1 antigen from Campylobacter jejuni
11/28/1995US5470955 Antibodies for binding monoclonal antibody polypeptides
11/28/1995US5470954 Antihemophelic factor separation by absorption
11/28/1995US5470953 Human β2 integrin α subunit
11/28/1995US5470952 Interleukin antagonists
11/28/1995US5470951 Alzheimer's
11/28/1995US5470950 Biologically active amphiphilic peptide compositions and uses therefor
11/28/1995US5470948 Vasopressin and vasotocin derivatives
11/28/1995US5470911 Biocompatibility
11/28/1995US5470842 Carbohydrate-based anti-inflammatory agents
11/28/1995US5470835 Transfer factor and methods of use
11/28/1995US5470831 Angiogenic peptides
11/28/1995US5470830 Motilin-like polypeptides that inhibit gastrointestinal motor activity
11/28/1995US5470828 Somatomedins, end group modification, growth regulators
11/28/1995US5470826 Single chain proteins with FHS suppressing activity isolated from follicular fluid and uses thereof
11/28/1995US5470825 Basophil granule proteins
11/28/1995US5470824 Method to treat Kaposi's sarcoma
11/28/1995US5470738 Diagnostic systems for assaying platelets in a vascular fluid
11/28/1995US5470736 Transdominant negative proto-oncogene
11/28/1995US5470735 Insecticidal plectoxins from Plectreurys tristis
11/28/1995US5470734 Recombinant herpesvirus of turkeys and live vector vaccines derived thereof
11/28/1995US5470730 Method for producing TH -independent cytotoxic T lymphocytes
11/28/1995US5470729 Method of isolating restriction fragment deletions in Vibrio cholerae, and products thereof
1 ... 2570 2571 2572 2573 2574 2575 2576 2577 2578 2579 2580 2581 2582 2583 2584 2585 2586 2587 2588 2589 2590 ... 2916